You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The ACLU is making its argument in federal court today against gene patenting, specifically against the BRCA1 and BRCA2 patents held by Myriad Genetics.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
Kaiser Health News reports San Francisco and Alameda counties in California are no longer using Verily Life Sciences' COVID-19 testing program.
The New York Times reports that developers in New York City are increasingly interested in life science spaces.
A UK study has found that antibodies against SARS-CoV-2 may decline over time, Reuters reports.
In PNAS this week: genetic and epigenetic variation in individuals with diabetic kidney disease, spontaneous genetic alterations in Saccharomyces cerevisiae, and more.